Acupuncture for Treatment of Acute Spinal Cord Injury: an Exploratory/Developmental Study

Spinal Cord Injury Clinical Trial

Official title: Acupuncture for Treatment of Acute Spinal Cord Injury

Status Completed

Clinical Trial Summary

Specific Aim: to implement and evaluate a research protocol for demonstrating the efficacy of Acupuncture Therapy to improve neurological recovery after incomplete SCI compared to a control protocol.

Hypothesis: acupuncture treatment results in greater neurological recovery than a control treatment after an incomplete SCI.

Before conducting a larger, more definitive study, this exploratory and developmental work is focused on assessing whether blinding is possible, reproducibility of the outcome measure, determine enrollment rates and effect sizes and identify clinical resources needed to conduct a larger study.

Clinical Trial Description

The research design for this exploratory/developmental R21 application will be the same as the anticipated design for a future definitive R01 investigation. A randomized controlled treatment study will be used to compare neurological recovery after spinal cord injury (SCI) in individuals receiving an acupuncture protocol designed to maximize treatment effectiveness (treatment protocol) with an alternative acupuncture protocol designed to minimize treatment effectiveness (control). The two acupuncture protocols will be identical except for 1) needle placement, 2) use of sham, non-penetrating needles and 3) use of electricity for needle stimulation. The two protocols are designed to be indistinguishable to an individual, so participants will remain blind to whether they are receiving the treatment or the control protocol.

Specific Aim: to implement and evaluate a research protocol for demonstrating the efficacy of Acupuncture Therapy to improve neurological recovery after incomplete SCI compared to a control protocol.

Hypothesis: acupuncture treatment results in greater neurological recovery than a control treatment after an incomplete SCI.

Before proposing a definitive R01 investigation to test this hypothesis, several preliminary steps are required and will be addressed in this feasibility study. Five objectives have been identified for the current R21 application as follows.

Objective 1 - Demonstrate that participants are unable to distinguish between treatment and control protocols, assuring participant blinding.

Objective 2 - Verify the inter-rater reliability of the primary outcome measures —the American Spinal Injury Association (ASIA) motor and sensory scores as defined by the ASIA Standards for Neurological Classification of SCI.1

Objective 3 - Collect pilot data for use in power analysis to determine the desired sample size in the definitive R01 investigation, including effect sizes, enrollment and dropout rates.

Objective 4 - Identify any unanticipated difficulties in implementing the treatment and control protocols and identify the clinical resources needed to conduct an R01 investigation.

Objective 5 - Prepare an application for an R01 definitive investigation including an operations manual for the protocol. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Spinal Cord Injuries
• Spinal Cord Injury

• NCT number: NCT00432289
• Study type: Interventional
• Source: Craig Hospital
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: November 2006
• Completion date: June 2009